Sector Investing

[ReturntoSender]

Stock market slips from record highs in front of eventful week
29-Jul-19 16:15 ET
Dow +28.90 at 27221.35, Nasdaq -36.88 at 8293.33, S&P -4.89 at 3020.97

https://www.briefing.com/investor/markets/stock-market-update/2019/7/29/stock-market-slips-from-record-highs-in-front-of-eventful-week.htm

[BRIEFING.COM] The S&P 500 lost 0.2% on Monday, slipping from record highs in a lackluster session. The Nasdaq Composite (-0.4%) and Russell 2000 (-0.6%) both underperformed, while the Dow Jones Industrial Average (+0.1%) managed to finish higher.

Monday's session didn't include much price action, as investors appeared to be waiting for several key events later this week. Some of these events will include the FOMC's rate decision, U.S.-China trade talks, the July employment report, and Apple's (AAPL 209.68, +1.94, +0.9%) earnings report. On a related note, Apple's price target was raised to $235 from $225 at UBS before its results after Tuesday's close.

Apple shares rose on the increased price target, but the broader market was still weighed down by widely-held shares of Amazon (AMZN 1912.45, -30.60, -1.6%), Facebook (FB 195.94, -3.81, -1.9%), and Alphabet (GOOG 1239.41, -11.00, -0.9%). In turn, the S&P 500 consumer discretionary (-0.6%) and communication services (-0.5%) sectors were among today's laggards but, like the broader market, finished the session off intraday lows.

The S&P 500 financials sector (-0.8%) succumbed to broad-based selling interest throughout the day. Wells Fargo (WFC 48.28, -1.02, -2.1%) was a notable laggard amid a Wall Street Journal report indicating that the Trump administration plans to make it harder for deeply indebted borrowers to acquire mortgage loans.

On the other hand, the S&P 500 defensive-oriented sectors -- utilities (+0.5%), real estate (+0.5%), health care (+0.4%), and consumer staples (+0.3%) -- were the lone sectors that finished higher.

Separately, Mylan N.V. (MYL 20.78, +2.32, +12.6%) agreed to combine with Pfizer's (PFE 41.45, -1.64, -3.8%) off-patent drug business, giving Mylan shareholders 43% of the combined company. On a related note, Mylan N.V. beat top and bottom-line estimates; Pfizer beat earnings estimates but missed revenue estimates.

U.S. Treasuries finished the session higher, pushing yields lower across the curve. The 2-yr yield and the 10-yr yield declined three basis points each to 1.84% and 2.06%, respectively. The U.S. Dollar Index finished flat at 98.04. WTI crude increased 1.2% to $56.87/bbl.

Investors did not receive any notable economic data on Monday.

Looking ahead, Tuesday will feature the Personal Income and Spending report for June, which will include the Fed's preferred inflation gauge -- the PCE Price Index. Investors will also receive the Conference Board's Consumer Confidence Index for July, Pending Home Sales for June, and the S&P Case-Shiller Home Price Index for May.

Nasdaq Composite +25.0% YTD
S&P 500 +20.5% YTD
Dow Jones Industrial Average +16.7% YTD
Russell 2000 +16.4% YTD